(Food-Beverage-News.Com, November 20, 2015 ) An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as "Orphan Designations" by the regulatory agencies to accelerate the approval process.
Market analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.
Covered in this report The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.
New report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions Americas APAC Europe
Key vendors Bristol-Mayer Squibb Celgene F. Hoffmann La Roche Novartis Pfizer
Other prominent vendors AbbVie Actelion Pharmaceuticals Alexion Pharmaceuticals Alnylam Pharmaceuticals Amgen AstraZeneca Baxter International Biogen Idec Celldex Therapeutics Eisai Eli Lilly GlaxoSmithKline Intercept Pharmaceuticals Johnson & Johnson Merck NewLink Genetics Northwest Biotherapeutics Novo Nordisk Onyx Pharmaceuticals Sanofi Shire Synageva BioPharma Takeda Vertex Pharmaceuticals XOMA
Market driver Shorter development timelines For a full, detailed list, view our report
Market challenge High cost of drug development For a full, detailed list, view our report
Market trend Increased focus on biological drugs For a full, detailed list, view our report
Key questions answered in this report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary Highlights PART 02: Scope of the report Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Overview Orphan medicines legislation Orphan medicines centralized procedure in US/EU Product registration process for orphan drugs in Japan Orphan drug designations and approvals Annual cost of orphan drugs R&D costs for orphan and non-orphan drugs PART 06: Pipeline snapshot PART 07: Market landscape Market overview Market size and forecast Five forces analysis PART 08: Market segmentation by product Global biologic orphan drugs market Global non-biologic orphan drugs market PART 09: Geographical segmentation Orphan drugs market in Americas Orphan drugs market in EMEA Orphan drugs market in APAC PART 10: Market drivers Shorter development timelines Assistance from regulatory bodies Incentives for developing orphan drugs High return on investment Exemption from pricing constraints
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
